Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dienstbier

Showing results (261-270 of 264) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 264 results.
Casopis Lekaru Ceskych|November 14, 1980
[Malignant lymphogranuloma. A retrospective study of a group of 430 patients]J Zámecník, V Kubec, T Cerná, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 27

Showing results (261-270 of 264) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 264 results.
Casopis Lekaru Ceskych|November 14, 1980
[Malignant lymphogranuloma. A retrospective study of a group of 430 patients]J Zámecník, V Kubec, T Cerná, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
ACS Central Science|June 1, 2022
Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 DimerizationSanil Bhatia, Lukas Spanier, David Bickel, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 27